Article
Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.
Circulation. Cardiovascular genetics - 1 Dec 2012
Chu Audrey Y, Guilianini Franco, Grallert Harald, Dupuis Josée, Ballantyne Christie M, Barratt Bryan J, Nyberg Fredrik, Chasman Daniel I, Ridker Paul M
Abstract excerpt
BACKGROUND: Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is a proinflammatory enzyme bound to low-density lipoprotein cholesterol and other circulating lipoproteins. Two measures of Lp-PLA(2), mass and activity, are associated with increased cardiovascular risk. Data are sparse regarding genetic determinants of Lp-PLA(2) mass and activity, and no prior data are available addressing genetic determinants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
